<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang R</submitter><funding>This study was supported by the Senior Medical Talents Program of Chongqing for Young and Middle-aged</funding><funding>the Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University</funding><funding>National Natural Science Foundation of China</funding><funding>the program of Science and Technology Bureau of Yuzhong District, Chongqing</funding><pagination>110</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10938667</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast cancer ranks first among malignant tumors, of which triple-negative breast cancer (TNBC) is characterized by its highly invasive behavior and the worst prognosis. Timely diagnosis and precise treatment of TNBC are substantially challenging. Abnormal tumor vessels play a crucial role in TNBC progression and treatment. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis, while effective NO delivery can normalize the tumor vasculature. Accordingly, we have proposed here a tumor vascular microenvironment remodeling strategy based on NO-induced vessel normalization and extracellular matrix collagen degradation with multimodality imaging-guided nanoparticles against TNBC called DNMF/PLGA.&lt;h4>Results&lt;/h4>Nanoparticles were synthesized using a chemotherapeutic agent doxorubicin (DOX), a NO donor L-arginine (L-Arg), ultrasmall spinel ferrites (MnFe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub>), and a poly (lactic-co-glycolic acid) (PLGA) shell. Nanoparticle distribution in the tumor was accurately monitored in real-time through highly enhanced magnetic resonance imaging and photoacoustic imaging. Near-infrared irradiation of tumor cells revealed that MnFe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> catalyzes the production of a large amount of reactive oxygen species (ROS) from H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>, resulting in a cascade catalysis of L-Arg to trigger NO production in the presence of ROS. In addition, DOX activates niacinamide adenine dinucleotide phosphate oxidase to generate and supply H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>. The generated NO improves the vascular endothelial cell integrity and pericellular contractility to promote vessel normalization and induces the activation of endogenous matrix metalloproteinases (mainly MMP-1 and MMP-2) so as to promote extravascular collagen degradation, thereby providing an auxiliary mechanism for efficient nanoparticle delivery and DOX penetration. Moreover, the chemotherapeutic effect of DOX and the photothermal effect of MnFe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> served as a chemo-hyperthermia synergistic therapy against TNBC.&lt;h4>Conclusion&lt;/h4>The two therapeutic mechanisms, along with an auxiliary mechanism, were perfectly combined to enhance the therapeutic effects. Briefly, multimodality image-guided nanoparticles provide a reliable strategy for the potential application in the fight against TNBC.</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.</pubmed_title><pmcid>PMC10938667</pmcid><funding_grant_id>kryc-gg-2117</funding_grant_id><funding_grant_id>81701709</funding_grant_id><funding_grant_id>2022-15</funding_grant_id><funding_grant_id>20200145</funding_grant_id><pubmed_authors>Du C</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Peng B</pubmed_authors><pubmed_authors>Ran H</pubmed_authors><pubmed_authors>Luo W</pubmed_authors><pubmed_authors>Cheng L</pubmed_authors><pubmed_authors>He L</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><pubmed_authors>Liu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.</name><description>&lt;h4>Background&lt;/h4>Breast cancer ranks first among malignant tumors, of which triple-negative breast cancer (TNBC) is characterized by its highly invasive behavior and the worst prognosis. Timely diagnosis and precise treatment of TNBC are substantially challenging. Abnormal tumor vessels play a crucial role in TNBC progression and treatment. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis, while effective NO delivery can normalize the tumor vasculature. Accordingly, we have proposed here a tumor vascular microenvironment remodeling strategy based on NO-induced vessel normalization and extracellular matrix collagen degradation with multimodality imaging-guided nanoparticles against TNBC called DNMF/PLGA.&lt;h4>Results&lt;/h4>Nanoparticles were synthesized using a chemotherapeutic agent doxorubicin (DOX), a NO donor L-arginine (L-Arg), ultrasmall spinel ferrites (MnFe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub>), and a poly (lactic-co-glycolic acid) (PLGA) shell. Nanoparticle distribution in the tumor was accurately monitored in real-time through highly enhanced magnetic resonance imaging and photoacoustic imaging. Near-infrared irradiation of tumor cells revealed that MnFe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> catalyzes the production of a large amount of reactive oxygen species (ROS) from H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>, resulting in a cascade catalysis of L-Arg to trigger NO production in the presence of ROS. In addition, DOX activates niacinamide adenine dinucleotide phosphate oxidase to generate and supply H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>. The generated NO improves the vascular endothelial cell integrity and pericellular contractility to promote vessel normalization and induces the activation of endogenous matrix metalloproteinases (mainly MMP-1 and MMP-2) so as to promote extravascular collagen degradation, thereby providing an auxiliary mechanism for efficient nanoparticle delivery and DOX penetration. Moreover, the chemotherapeutic effect of DOX and the photothermal effect of MnFe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> served as a chemo-hyperthermia synergistic therapy against TNBC.&lt;h4>Conclusion&lt;/h4>The two therapeutic mechanisms, along with an auxiliary mechanism, were perfectly combined to enhance the therapeutic effects. Briefly, multimodality image-guided nanoparticles provide a reliable strategy for the potential application in the fight against TNBC.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-24T03:09:40.488Z</modification><creation>2026-06-24T03:06:17.872Z</creation></dates><accession>S-EPMC10938667</accession><cross_references><pubmed>38481281</pubmed><doi>10.1186/s12951-024-02366-y</doi></cross_references></HashMap>